VIIV healthcare
Overview
ViiV Healthcare is a global pharmaceutical company exclusively dedicated to the research, development, and delivery of innovative treatments for HIV/AIDS. Established in 2009 as a joint venture between GlaxoSmithKline (GSK) and Pfizer, with Shionogi joining in 2012, ViiV Healthcare combines the expertise and resources of its parent companies to focus solely on combating HIV. ViiV Healthcare's mission is to ensure that no person living with HIV is left behind. To achieve this, the company has developed a portfolio of 17 prescription medicines, including single-pill regimens and long-acting injectables, which account for approximately 32% of the global HIV therapy market, making it the second-largest company in this sector after Gilead Sciences. Notable products include Triumeq, Dovato, and Cabenuva, among others. Beyond developing treatments, ViiV Healthcare is committed to improving access to its medicines, particularly in low- and middle-income countries. The company has implemented not-for-profit pricing schemes and granted voluntary licenses to generic manufacturers to produce affordable versions of its drugs, ensuring broader access to essential HIV medications.
Profile Information
Contact Information
Procurement Notices by VIIV healthcare
Subscriber Only Content
Current and Previous Partners Worked With VIIV healthcare
Subscriber Only Content